[Retinoblastoma update--therapy (Part II)].
The aim of this paper is to present updated data on the treatment of retinoblastoma. The authors describe current management based on the International Intraocular Retinoblastoma Classification (IIRC). They discuss the different methods of treatment, including chemoreduction, subconjunctival carboplatin, transpupillar thermotherapy, cryotherapy, laser photocoagulation, episcleral plaque radiotherapy, external-beem radiotherapy and enucleation.
Pogrzebielski
Arkadiusz
A
Katedry i Kliniki Okulistyki i Onkologii, Okulistycznej Collegium Medicum Uniwersytetu Jagiellońskiego.
Shields
Carol L
CL
Romanowska-Dixon
Bozena
B
Shields
Jerry A
JA
D000970:Antineoplastic Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001918:Brachytherapy / Q000639:trends; D016190:Carboplatin / Q000627:therapeutic use; D003131:Combined Modality Therapy; D017679:Cryotherapy / Q000639:trends; D015353:Eye Enucleation; D005134:Eye Neoplasms / Q000628:therapy*; D006801:Humans; D017075:Laser Coagulation / Q000639:trends; D009364:Neoplasm Recurrence, Local; D012175:Retinoblastoma / Q000628:therapy*; D012189:Retrospective Studies; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D014750:Vincristine; D016190:Carboplatin